152 related articles for article (PubMed ID: 15339694)
61. Long-term remission of lymphocytic hypereosinophilic syndrome with imatinib mesylate.
Christoforidou A; Kotsianidis I; Margaritis D; Anastasiadis A; Douvali E; Tsatalas C
Am J Hematol; 2012 Jan; 87(1):131-2. PubMed ID: 21919038
[No Abstract] [Full Text] [Related]
62. [Sustained hematologic response in chronic eosinophilic leukemia with low dose imatinib. Report of one case].
Torres C D; ChandÃa M
Rev Med Chil; 2014 Apr; 142(4):516-20. PubMed ID: 25117044
[TBL] [Abstract][Full Text] [Related]
63. Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.
Lyall H; O'Connor S; Clark D
Br J Haematol; 2007 Aug; 138(4):405. PubMed ID: 17593250
[No Abstract] [Full Text] [Related]
64. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
Garg A; Duggal L; Aggarwal S; Jain N
J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
[TBL] [Abstract][Full Text] [Related]
65. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
66. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
Scheinfeld N
J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
[TBL] [Abstract][Full Text] [Related]
67. Imatinib-mesylate for all patients with hypereosinophilic syndrome?
Musto P; Perla G; Minervini MM; Carella AM; Coco FL; Catalano G
Leuk Res; 2004 Jul; 28(7):773-4. PubMed ID: 15158099
[No Abstract] [Full Text] [Related]
68. Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate.
Coutré S; Gotlib J
Semin Cancer Biol; 2004 Aug; 14(4):307-15. PubMed ID: 15305431
[TBL] [Abstract][Full Text] [Related]
69. [The efficacy of imatinib mesylate for patients with myeloproliferative neoplasm (MPN) with eosinophilia].
Zhang Y; Qin TJ; Zhou CL; Liu L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):381-4. PubMed ID: 19951530
[TBL] [Abstract][Full Text] [Related]
70. [Chronic eosinophilic leukemia].
Ouakaa-Kchaou A; Belhadj N; Ennaifer R; Hefaiedh R; Elloumi H; Gargouri D; Ghorbel A
Tunis Med; 2009 Apr; 87(4):303. PubMed ID: 19835296
[No Abstract] [Full Text] [Related]
71. [Clonal eosinophilia revealed by recurrent Staphylococcus aureus infection].
Vandenbos F; Figueredo M; Dumon-Gubeno MC; Nicolle I; Tarhini A; Medioni LD; Naman H; Mouroux J
Rev Pneumol Clin; 2011 Jun; 67(3):167-9. PubMed ID: 21665081
[TBL] [Abstract][Full Text] [Related]
72. Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
Li Z; Yang R; Zhao J; Yuan R; Lu Q; Li Q; Tse W
Pediatr Blood Cancer; 2011 Mar; 56(3):463-6. PubMed ID: 21072821
[TBL] [Abstract][Full Text] [Related]
73. Cell clonality in hypereosinophilic syndrome: what pathogenetic role?
Galimberti S; Ciabatti E; Ottimo F; Rossi A; Trombi L; Carulli G; Cervetti G; Matti L; Bianchi G; Petrini M
Clin Exp Rheumatol; 2007; 25(1):17-22. PubMed ID: 17417985
[TBL] [Abstract][Full Text] [Related]
74. Novel approaches to therapy of hypereosinophilic syndromes.
Simon HU; Cools J
Immunol Allergy Clin North Am; 2007 Aug; 27(3):519-27. PubMed ID: 17868862
[TBL] [Abstract][Full Text] [Related]
75. Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.
Iurlo A; Gianelli U; Beghini A; Spinelli O; Orofino N; Lazzaroni F; Cambiaghi S; Intermesoli T; Rambaldi A; Cortelezzi A
Oncotarget; 2014 Jul; 5(13):4665-70. PubMed ID: 25015329
[TBL] [Abstract][Full Text] [Related]
76. Chronic eosinophilic leukemia with FIP1L1-PDGFRA.
Verdu J; de Paz F
Blood; 2013 Feb; 121(8):1254. PubMed ID: 23550302
[No Abstract] [Full Text] [Related]
77. Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia.
Awano N; Ryu T; Yoshimura N; Takazoe M; Kitamura S; Tanaka M
Intern Med; 2011; 50(16):1741-5. PubMed ID: 21841337
[TBL] [Abstract][Full Text] [Related]
78. Systemic mastocytosis: bone marrow pathology, classification, and current therapies.
Pardanani A
Acta Haematol; 2005; 114(1):41-51. PubMed ID: 15995324
[TBL] [Abstract][Full Text] [Related]
79. Elevated serum levels of soluble interleukin-2 receptor in chronic eosinophilic leukemia/hypereosinophilic syndrome with FIP1L1-PDGFR alpha fusion gene.
Kataoka K; Izutsu K; Nagai S; Hangaishi A; Motokura T; Takahashi T; Kurokawa M
Int J Hematol; 2008 May; 87(4):440-441. PubMed ID: 18365140
[No Abstract] [Full Text] [Related]
80. Chronic eosinophilic leukaemia revealed by lymphomatoid papulosis: the role of the FIP1-like 1-platelet-derived growth factor receptor alpha fusion gene.
Thuny C; Gaudy-Marqueste C; Nicol I; Gabert J; Costello R; Grob JJ; Richard MA
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):234-5. PubMed ID: 19686260
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
